Coupling enrichment methods with proteomics for understanding and treating disease

Proteomics - Clinical Applications

Volumn 9, Issue 1-2, 2015, Pages 33-47

  Kumar, Amit ^a,b,c   Baycin Hizal, Deniz ^b   Shiloach, Joseph ^c   Bowen, Michael A ^b   Betenbaugh, Michael J ^a  

^a Whiting School of Engineering   (United States)

^b MEDIMMUNE   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Biomarker discovery; Drug target discovery; Exosomes; MAb discovery; Membrane proteomics

Indexed keywords

CATION; CELL MEMBRANE PROTEIN; GLYCOPROTEOME; MONOCLONAL ANTIBODY; NANOPARTICLE; PROTEOME; UNCLASSIFIED DRUG; PROTEIN;

ANALYTIC METHOD; AUTOIMMUNE DISEASE; BIOINFORMATICS; BIOTINYLATION; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CELL FRACTIONATION; CELL SURFACE; COUPLING ENRICHMENT METHOD; DISEASE MARKER; DRUG MECHANISM; DRUG RESEARCH; DRUG SYNTHESIS; DRUG TARGETING; EXOSOME; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; MALIGNANT NEOPLASTIC DISEASE; MEMBRANE BIOLOGY; NEUROLOGIC DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PROTEOMICS; REVIEW; ULTRACENTRIFUGATION; AFFINITY CHROMATOGRAPHY; ANIMAL; DISEASES; ISOLATION AND PURIFICATION; METABOLISM; PROCEDURES;

ANIMALIA;

ANIMALS; CHROMATOGRAPHY, AFFINITY; DISEASE; HUMANS; PROTEINS; PROTEOME; PROTEOMICS;

EID: 84922801793     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201400097     Document Type: Review

References (169)

1. Legrain, P., Aebersold, R., Archakov, A., Bairoch, A. et al., The human proteome project: current state and future direction. Mol. Cell. Proteomics 2011, 10, M111 009993.
2. Mermelekas, G., Zoidakis, J., Mass spectrometry-based membrane proteomics in cancer biomarker discovery. Expert. Rev. Mol. Diagn. 2014, 14, 549-563.
3. Jimenez, C. R., Verheul, H. M., Mass spectrometry-based proteomics: from cancer biology to protein biomarkers, drug targets, and clinical applications. Am. Soc. Clin. Oncol. Educ. Book 2014, 34, e504-e510.
4. Gomez-Cabrero, D., Abugessaisa, I., Maier, D., Teschendorff, A. et al., Data integration in the era of omics: current and future challenges. BMC Syst. Biol. 2014, 8 (Suppl 2), I1.
5. Kandoth, C., Schultz, N., Cherniack, A. D., Akbani, R. et al., Integrated genomic characterization of endometrial carcinoma. Nature 2013, 497, 67-73.
6. Doroudgar, S., Glembotski, C. C., The cardiokine story unfolds: ischemic stress-induced protein secretion in the heart. Trends Mol. Med. 2011, 17, 207-214.
7. Celis, J. E., Gromov, P., Cabezon, T., Moreira, J. M. et al., Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery. Mol. Cell Proteomics 2004, 3, 327-344.
8. Gromov, P., Gromova, I., Bunkenborg, J., Cabezon, T. et al., Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast. Mol. Oncol. 2010, 4, 65-89.
9. Raimondo, F., Morosi, L., Chinello, C., Magni, F. et al., Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery. Proteomics 2011, 11, 709-720.
10. Dowling, P., Clynes, M., Conditioned media from cell lines: a complementary model to clinical specimens for the discovery of disease-specific biomarkers. Proteomics 2011, 11, 794-804.
11. Kolarich, D., Lepenies, B., Seeberger, P. H., Glycomics, glycoproteomics and the immune system. Curr. Opin. Chem. Biol. 2012, 16, 214-220.
12. Kim, E. H., Misek, D. E., Glycoproteomics-based identification of cancer biomarkers. Int. J. Proteomics 2011, 2011, 601937.
13. Hanahan, D., Weinberg, R. A., The hallmarks of cancer. Cell 2000, 100, 57-70.
14. Corless, C. L., Fletcher, J. A., Heinrich, M. C., Biology of gastrointestinal stromal tumors. J. Clin. Oncol. 2004, 22, 3813-3825.
15. Choudhary, C., Olsen, J. V., Brandts, C., Cox, J. et al., Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes. Mol. Cell 2009, 36, 326-339.
16. Amanchy, R., Kalume, D. E., Iwahori, A., Zhong, J. et al., Phosphoproteome analysis of HeLa cells using stable isotope labeling with amino acids in cell culture (SILAC). J. Proteome Res. 2005, 4, 1661-1671.
17. Amanchy, R., Zhong, J., Molina, H., Chaerkady, R. et al., Identification of c-Src tyrosine kinase substrates using mass spectrometry and peptide microarrays. J. Proteome Res. 2008, 7, 3900-3910.
18. Gulmann, C., Sheehan, K. M., Conroy, R. M., Wulfkuhle, J. D. et al., Quantitative cell signalling analysis reveals down-regulation of MAPK pathway activation in colorectal cancer. J. Pathol. 2009, 218, 514-519.
19. Zhong, D., Liu, X., Khuri, F. R., Sun, S. Y. et al., LKB1 is necessary for Akt-mediated phosphorylation of proapoptotic proteins. Cancer. Res. 2008, 68, 7270-7277.
20. Schindler, J., Jung, S., Niedner-Schatteburg, G., Friauf, E. et al., Enrichment of integral membrane proteins from small amounts of brain tissue. J. Neural. Transm. 2006, 113, 995-1013.
21. Kohnke, P. L., Mulligan, S. P., Christopherson, R. I., Membrane proteomics for leukemia classification and drug target identification. Curr. Opin. Mol. Ther. 2009, 11, 603-610.
22. Lehner, I., Niehof, M., Borlak, J., An optimized method for the isolation and identification of membrane proteins. Electrophoresis 2003, 24, 1795-1808.
23. Donovan, L. E., Higginbotham, L., Dammer, E. B., Gearing, M. et al., Analysis of a membrane-enriched proteome from postmortem human brain tissue in Alzheimer's disease. Proteomics Clin. Appl. 2012, 6, 201-211.
24. Raimondo, F., Morosi, L., Chinello, C., Perego, R. et al., Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples. Mol. Biosyst. 2012, 8, 1007-1016.
25. Zhang, Q., Schulenborg, T., Tan, T., Lang, B. et al. Proteome analysis of a plasma membrane-enriched fraction at the placental feto-maternal barrier. Proteomics Clin. Appl. 2010, 4, 538-549.
26. Elia, G., Cell surface protein biotinylation for SDS-PAGE analysis. Methods Mol. Biol. 2012, 869, 361-372.
27. Yokoyama, T., Enomoto, T., Serada, S., Morimoto, A. et al., Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer. Int. J. Cancer 2013, 132, 472-484.
28. Qi, Y., Katagiri, F., Purification of low-abundance Arabidopsis plasma-membrane protein complexes and identification of candidate components. Plant J. 2009, 57, 932-944.
29. Tian, Y., Koganti, T., Yao, Z., Cannon, P. et al., Cardiac extracellular proteome profiling and membrane topology analysis using glycoproteomics. Prot. Clin. Appl. 2014, 8, 595-602.
30. Liu, Y., Chen, J., Sethi, A., Li, Q. K. et al., Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness. Mol. Cell Proteomics 2014, 13, 1753-1768.
31. Baycin Hizal D., Wolozny, D., Colao, J., Jacobson, E. et al. Glycoproteomic and glycomic databases. Clin. Proteomics 2014, 11, 15.
32. Yang, W., Zhou, J. Y., Chen, L., Ao, M. et al. Glycoproteomic analysis identifies human glycoproteins secreted from HIV latently infected T cells and reveals their presence in HIV+ plasma. Clin. Proteomics 2014, 11, 9.
33. Chen, J., Xi, J., Tian, Y., Bova, G. S., et al., Identification, prioritization, and evaluation of glycoproteins for aggressive prostate cancer using quantitative glycoproteomics and antibody-based assays on tissue specimens. Proteomics 2013, 13, 2268-2277.
34. Tian, Y., Zhang, H., Characterization of disease-associated N-linked glycoproteins. Proteomics 2013, 13, 504-511.
35. Li, Q. K., Gabrielson, E., Zhang, H., Application of glycoproteomics for the discovery of biomarkers in lung cancer. Proteomics Clin. Appl. 2012, 6, 244-256.
36. Almaraz, R. T., Tian, Y., Bhattarcharya, R., Tan, E. et al., Metabolic flux increases glycoprotein sialylation: implications for cell adhesion and cancer metastasis. Mol. Cell Proteomics 2012, 11, M112 017558.
37. Liu, Y., Huttenhain, R., Surinova, S., Gillet, L. C. et al., Quantitative measurements of N-linked glycoproteins in human plasma by SWATH-MS. Proteomics 2013, 13, 1247-1256.
38. Huttenhain, R., Surinova, S., Ossola, R., Sun, Z. et al., N-glycoprotein SRMAtlas: a resource of mass spectrometric assays for N-glycosites enabling consistent and multiplexed protein quantification for clinical applications. Mol. Cell Proteomics 2013, 12, 1005-1016.
39. Cerciello, F., Choi, M., Nicastri, A., Bausch-Fluck, D. et al., Identification of a seven glycopeptide signature for malignant pleural mesothelioma in human serum by selected reaction monitoring. Clin. Proteomics 2013, 10, 16.
40. Ahn, Y. H., Kim, J. Y., Yoo, J. S. Quantitative mass spectrometric analysis of glycoproteins combined with enrichment methods. Mass Spectrom. Rev. 2014, doi: 10.1002/mas.21428
41. Xu, Y., Bailey, U. M., Punyadeera, C., Schulz, B. L., Identification of salivary N-glycoproteins and measurement of glycosylation site occupancy by boronate glycoprotein enrichment and liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2014, 28, 471-482.
42. Wollscheid, B., Bausch-Fluck, D., Henderson, C., O'Brien, R. et al., Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins. Nat. Biotechnol. 2009, 27, 378-386.
43. Baycin-Hizal, D., Tian, Y., Akan, I., Jacobson, E. et al., GlycoFly: a database of drosophila N-linked glycoproteins identified using SPEG-MS techniques. J. Proteome Res. 2011, 10, 2777-2784.
44. Tian, Y., Zhou, Y., Elliott, S., Aebersold, R. et al., Solid-phase extraction of N-linked glycopeptides. Nat. Protoc. 2007, 2, 334-339.
45. Lee, M. C., Sun, B., Glycopeptide capture for cell surface proteomics. J. Vis. Exp. 2014, 87, e51349.
46. Sun, Z., Chen, R., Cheng, K., Liu, H. et al., A new method for quantitative analysis of cell surface glycoproteome. Proteomics 2012, 12, 3328-3337.
47. Han, D., Moon, S., Kim, Y., Min, H. et al., Characterization of the membrane proteome and N-glycoproteome in BV-2 mouse microglia by liquid chromatography-tandem mass spectrometry. BMC Genomics 2014, 15, 95.
48. Zhang, H., Li, X. J., Martin, D. B., Aebersold, R., Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry. Nat. Biotechnol. 2003, 21, 660-666.
49. Ramya, T. N., Weerapana, E., Cravatt, B. F., Paulson, J. C. Glycoproteomics enabled by tagging sialic acid- or galactose-terminated glycans. Glycobiology 2013, 23, 211-221.
50. Choksawangkarn, W., Kim, S. K., Cannon, J. R., Edwards, N. J. et al., Enrichment of plasma membrane proteins using nanoparticle pellicles: comparison between silica and higher density nanoparticles. J. Proteome Res. 2013, 12, 1134-1141.
51. Kim, Y., Elschenbroich, S., Sharma, P., Sepiashvili, L. et al., Use of colloidal silica-beads for the isolation of cell-surface proteins for mass spectrometry-based proteomics. Methods Mol. Biol. 2011, 748, 227-241.
52. Vandre, D. D., Ackerman, W. E. t., Tewari, A., Kniss, D. A. et al., A placental sub-proteome: the apical plasma membrane of the syncytiotrophoblast. Placenta 2012, 33, 207-213.
53. Li, X., Jin, Q., Cao, J., Xie, C. et al., Evaluation of two cell surface modification methods for proteomic analysis of plasma membrane from isolated mouse hepatocytes. Biochim. Biophys. Acta 2009, 1794, 32-41.
54. Li, X., Xie, C., Cao, J., He, Q. et al., An in vivo membrane density perturbation strategy for identification of liver sinusoidal surface proteome accessible from the vasculature. J. Proteome Res. 2009, 8, 123-132.
55. Schiess, R., Mueller, L. N., Schmidt, A., Mueller, M. et al., Analysis of cell surface proteome changes via label-free, quantitative mass spectrometry. Mol. Cell Proteomics 2009, 8, 624-638.
56. Zhang, H., Liu, A. Y., Loriaux, P., Wollscheid, B. et al., Mass spectrometric detection of tissue proteins in plasma. Mol. Cell Proteomics 2007, 6, 64-71.
57. Gillet, L. C., Navarro, P., Tate, S., Rost, H. et al., Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol. Cell Proteomics 2012, 11, O111 016717.
58. Liu, Y., Huttenhain, R., Collins, B., Aebersold, R., Mass spectrometric protein maps for biomarker discovery and clinical research. Expert. Rev. Mol. Diagn 2013, 13, 811-825.
59. Zhang, H., Yi, E. C., Li, X. J., Mallick, P. et al., High throughput quantitative analysis of serum proteins using glycopeptide capture and liquid chromatography mass spectrometry. Mol. Cell Proteomics 2005, 4, 144-155.
60. Herbrich, S. M., Cole, R. N., West, K. P., Jr., Schulze, K. et al., Statistical inference from multiple iTRAQ experiments without using common reference standards. J. Proteome Res. 2013, 12, 594-604.
61. Yan, M., Yang, X., Wang, L., Clark, D. et al., Plasma membrane proteomics of tumor spheres identify CD166 as a novel marker for cancer stem-like cells in head and neck squamous cell carcinoma. Mol. Cell Proteomics 2013, 12, 3271-3284.
62. Kaji, H., Saito, H., Yamauchi, Y., Shinkawa, T. et al., Lectin affinity capture, isotope-coded tagging and mass spectrometry to identify N-linked glycoproteins. Nat. Biotechnol. 2003, 21, 667-672.
63. Zhang, W., Zhou, G., Zhao, Y., White, M. A. et al., Affinity enrichment of plasma membrane for proteomics analysis. Electrophoresis 2003, 24, 2855-2863.
64. Warder, S.E., Tucker, L. A., Strelitzer, T. J., McKeegan, E. M. et al., Reducing agent-mediated precipitation of high-abundance plasma proteins. Anal. Biochem. 2009, 387, 184-193.
65. Holewinski, R. J., Jin, Z. C., Powell, M. J., Maust, M. D. et al., A fast and reproducible method for albumin isolation and depletion from serum and cerebrospinal fluid. Proteomics 2013, 13, 743-750.
66. An, Y., Goldman, R., Analysis of peptides by denaturing ultrafiltration and LC-MALDI-TOF-MS. Methods Mol. Biol. 2013, 1023, 13-19.
67. Ortea, I., Roschitzki, B., Ovalles, J. G., Longo, J. L. et al., Discovery of serum proteomic biomarkers for prediction of response to infliximab (a monoclonal anti-TNF antibody) treatment in rheumatoid arthritis: an exploratory analysis. J. Proteomics 2012, 77, 372-382.
68. Cole, R. N., Ruczinski, I., Schulze, K., Christian, P. et al., The plasma proteome identifies expected and novel proteins correlated with micronutrient status in undernourished nepalese children. J. Nutr. 2013, 143, 1540-1548.
69. Lee, E. K., Cho, H., Kim, C. W., Proteomic analysis of cancer stem cells in human prostate cancer cells. Biochem. Biophys. Res. Commun. 2011, 412, 279-285.
70. Rush, J., Moritz, A., Lee, K. A., Guo, A. et al., Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 2005, 23, 94-101.
71. Luo, W., Slebos, R. J., Hill, S., Li, M. et al., Global impact of oncogenic Src on a phosphotyrosine proteome. J. Proteome Res. 2008, 7, 3447-3460.
72. Iwai, L. K., Benoist, C., Mathis, D., White, F. M., Quantitative phosphoproteomic analysis of T cell receptor signaling in diabetes prone and resistant mice. J. Proteome Res. 2010, 9, 3135-3145.
73. Watkin, E. E., Arbez, N., Waldron-Roby, E., O'Meally, R. et al., Phosphorylation of mutant huntingtin at serine 116 modulates neuronal toxicity. PLoS One 2014, 9, e88284.
74. Zhong, J., Kim, M. S., Chaerkady, R., Wu, X. et al., TSLP signaling network revealed by SILAC-based phosphoproteomics. Mol. Cell Proteomics 2012, 11, M112 017764.
75. Mitsos, A., Melas, I. N., Siminelakis, P., Chairakaki, A. D. et al., Identifying drug effects via pathway alterations using an integer linear programming optimization formulation on phosphoproteomic data. PLoS Comput. Biol. 2009, 5, e1000591.
76. Brill, L. M., Xiong, W., Lee, K. B., Ficarro, S. B. et al., Phosphoproteomic analysis of human embryonic stem cells. Cell Stem Cell 2009, 5, 204-213.
77. Kaminska, B., MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits. Biochim. Biophys. Acta 2005, 1754, 253-262.
78. Peifer, C., Wagner, G., Laufer, S., New approaches to the treatment of inflammatory disorders small molecule inhibitors of p38 MAP kinase. Curr. Top Med. Chem. 2006, 6, 113-149.
79. White, M. F., Regulating insulin signaling and beta-cell function through IRS proteins. Can. J. Physiol. Pharmacol. 2006, 84, 725-737.
80. Smith, F. D., Samelson, B. K., Scott, J. D., Discovery of cellular substrates for protein kinase A using a peptide array screening protocol. Biochem. J. 2011, 438, 103-110.
81. Min-Sik Kim, Y. Z., Shinchi Yachida, N. V., Kumar R., Abel M. L. et al., Heterogeneity of pancreatic cancer metastases in a single patient revealed by quantitative proteomics. Am. Soc. Biochem. Mol. Biol. 2014, 13, 2803-2811.
82. Amanchy, R., Kandasamy, K., Mathivanan, S., Periaswamy, B. et al., Identification of novel phosphorylation motifs through an integrative computational and experimental analysis of the human phosphoproteome. J. Proteomics Bioinform. 2011, 4, 22-35.
83. Peri, S., Navarro, J. D., Kristiansen, T. Z., Amanchy, R. et al., Human protein reference database as a discovery resource for proteomics. Nucleic Acids Res. 2004, 32, D497-D501.
84. Peri, S., Navarro, J. D., Amanchy, R., Kristiansen, T. Z. et al., Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Res. 2003, 13, 2363-2371.
85. Mathivanan, S., Ahmed, M., Ahn, N. G., Alexandre, H. et al., Human Proteinpedia enables sharing of human protein data. Nat. Biotechnol. 2008, 26, 164-167.
86. Kandasamy, K., Keerthikumar, S., Goel, R., Mathivanan, S. et al., Human Proteinpedia: a unified discovery resource for proteomics research. Nucleic Acids Res. 2009, 37, D773-D781.
87. Goel, R., Harsha, H. C., Pandey, A., Prasad, T. S., Human Protein Reference Database and Human Proteinpedia as resources for phosphoproteome analysis. Mol. Biosyst. 2012, 8, 453-463.
88. McLachlin, D. T., Chait, B. T., Analysis of phosphorylated proteins and peptides by mass spectrometry. Curr. Opin. Chem. Biol. 2001, 5, 591-602.
89. Aebersold, R., Mann, M., Mass spectrometry-based proteomics. Nature 2003, 422, 198-207.
90. Maguire, P. B., Wynne, K. J., Harney, D. F., O'Donoghue, N. M. et al., Identification of the phosphotyrosine proteome from thrombin activated platelets. Proteomics 2002, 2, 642-648.
91. Zheng, H., Hu, P., Quinn, D. F., Wang, Y. K., Phosphotyrosine proteomic study of interferon alpha signaling pathway using a combination of immunoprecipitation and immobilized metal affinity chromatography. Mol. Cell Proteomics 2005, 4, 721-730.
92. Molina, H., Horn, D. M., Tang, N., Mathivanan, S. et al., Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry. Proc. Natl. Acad. Sci. USA 2007, 104, 2199-2204.
93. Bose, R., Molina, H., Patterson, A. S., Bitok, J. K. et al., Phosphoproteomic analysis of Her2/neu signaling and inhibition. Proc. Natl. Acad. Sci. USA 2006, 103, 9773-9778.
94. Harsha, H. C., Molina, H., Pandey, A., Quantitative proteomics using stable isotope labeling with amino acids in cell culture. Nat. Protoc. 2008, 3, 505-516.
95. Olsen, J. V., Blagoev, B., Gnad, F., Macek, B. et al., Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006, 127, 635-648.
96. Nagaraj, N., D'Souza, R. C., Cox, J., Olsen, J. V. et al., Feasibility of large-scale phosphoproteomics with higher energy collisional dissociation fragmentation. J. Proteome Res. 2010, 9, 6786-6794.
97. Han, G., Ye, M., Liu, H., Song, C. et al., Phosphoproteome analysis of human liver tissue by long-gradient nanoflow LC coupled with multiple stage MS analysis. Electrophoresis 2010, 31, 1080-1089.
98. Oyama, M., Kozuka-Hata, H., Tasaki, S., Semba, K. et al., Temporal perturbation of tyrosine phosphoproteome dynamics reveals the system-wide regulatory networks. Mol. Cell Proteomics 2009, 8, 226-231.
99. Li, H., Ren, Z., Kang, X., Zhang, L. et al., Identification of tyrosine-phosphorylated proteins associated with metastasis and functional analysis of FER in human hepatocellular carcinoma cells. BMC Cancer 2009, 9, 366.
100. Garnier, D. J. N., Rak, J., Extracellular vesicles as prospective carriers of oncogenic protein signatures in adult and paediatric brain tumors. Proteomics 2012, 13, 1595-1607.
101. Kucharzewska, P., Christianson, H. C., Welch, J. E., Svensson, K. J. et al., Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc. Natl. Acad. Sci. USA 2013, 110, 7312-7317.
102. Yang, M., Chen, J., Su, F., Yu, B. et al., Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol. Cancer 2011, 10, 117.
103. Thomas, S. N., Liao, Z., Clark, D., Chen, Y. et al., Exosomal proteome profiling: a potential multi-marker cellular phenotyping tool to characterize hypoxia-induced radiation resistance in breast cancer. Proteomes 2013, 1, 87-108.
104. Klinke, D. J., 2nd, Kulkarni, Y. M., Wu, Y., Byrne-Hoffman, C., Inferring alterations in cell-to-cell communication in HER2+ breast cancer using secretome profiling of three cell models. Biotechnol. Bioeng. 2014, 111, 1853-1863.
105. Amorim, M., Fernandes, G., Oliveira, P., Martins-de-Souza, D. et al., The overexpression of a single oncogene (ERBB2/HER2) alters the proteomic landscape of extracellular vesicles. Proteomics 2014, 14, 1472-1479.
106. Yoon, J. H., Kim, J., Kim, K. L., Kim, D. H. et al., Proteomic analysis of hypoxia-induced U373MG glioma secretome reveals novel hypoxia-dependent migration factors. Proteomics 2014, 14, 1494-1502.
107. Drake, R. R., Kislinger, T., The proteomics of prostate cancer exosomes. Expert. Rev. Proteomics 2014, 11, 167-177.
108. Beckham, C. J., Olsen, J., Yin, P. N., Wu, C. H. et al., Bladder cancer exosomes contain EDIL-3/del1 and facilitate cancer progression. J. Urol. 2014, 192, 583-592.
109. Webber, J., Stone, T. C., Katilius, E., Smith, B. C., Gordon, B. et al., Proteomics analysis of cancer exosomes using a novel modified aptamer-based array (SOMAscan) platform. Mol. Cell Proteomics 2014, 13, 1050-1064.
110. Sinha, A., Ignatchenko, V., Ignatchenko, A., Mejia-Guerrero, S. et al., In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome. Biochem. Biophys. Res. Commun. 2014, 445, 694-701.
111. Jeppesen, D. K., Nawrocki, A., Jensen, S. G., Thorsen, K. et al., Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors. Proteomics 2014, 14, 699-712.
112. Bijnsdorp, I. V., Geldof, A. A., Lavaei, M., Piersma, S. R. et al., Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients. J. Extracell Vesicles 2013, 2, doi: 10.3402/jev.v2i0.22097
113. Shin, S. J., Smith, J. A., Rezniczek, G. A., Pan, S. et al., Unexpected gain of function for the scaffolding protein plectin due to mislocalization in pancreatic cancer. Proc. Natl. Acad. Sci. USA 2013, 110, 19414-19419.
114. Camacho, L., Guerrero, P., Marchetti, D., MicroRNA and protein profiling of brain metastasis competent cell-derived exosomes. PLoS One 2013, 8, e73790.
115. Nyalwidhe, J. O., Betesh, L. R., Powers, T. W., Jones, E. E. et al., Increased bisecting N-acetylglucosamine and decreased branched chain glycans of N-linked glycoproteins in expressed prostatic secretions associated with prostate cancer progression. Proteomics Clin. Appl. 2013, 677-689. doi: 10.1002/prca.201200134
116. Park, J. O., Choi, D. Y., Choi, D. S., Kim, H. J. et al., Identification and characterization of proteins isolated from microvesicles derived from human lung cancer pleural effusions. Proteomics 2013, 13, 2125-2134.
117. Raimondo, F., Morosi, L., Corbetta, S., Chinello, C. et al., Differential protein profiling of renal cell carcinoma urinary exosomes. Mol. Biosyst. 2013, 9, 1220-1233.
118. Dominy, S. S., Brown, J. N., Ryder, M. I., Gritsenko, M. et al., Proteomic analysis of saliva in HIV-positive heroin addicts reveals proteins correlated with cognition. PLoS One 2014, 9, e89366.
119. Jaworski, E., Saifuddin, M., Sampey, G., Shafagati, N. et al., The use of nanotrap particles technology in capturing HIV-1 virions and viral proteins from infected cells. PLoS One 2014, 9, e96778.
120. Hassani, K., Shio, M. T., Martel, C., Faubert, D. et al., Absence of metalloprotease GP63 alters the protein content of leishmania exosomes. PLoS One 2014, 9, e95007.
121. Kang, G. Y., Bang, J. Y., Choi, A. J., Yoon, J. et al., Exosomal proteins in the aqueous humor as novel biomarkers in patients with neovascular age-related macular degeneration. J. Proteome Res. 2014, 13, 581-595.
122. Bellingham, S. A., Guo, B. B., Coleman, B. M., Hill, A. F., Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases? Front Physiol. 2012, 3, 124.
123. Chiasserini, D., van Weering, J. R., Piersma, S. R., Pham, T. V. et al., Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset. J. Proteomics 2014, 106C, 191-204.
124. Rodriguez-Suarez, E., Gonzalez, E., Hughes, C., Conde-Vancells, J. et al., Quantitative proteomic analysis of hepatocyte-secreted extracellular vesicles reveals candidate markers for liver toxicity. J. Proteomics 2014, 103, 227-240.
125. Redzic, J. S., Ung, T. H., Graner, M. W., Glioblastoma extracellular vesicles: reservoirs of potential biomarkers. Pharmgenomics Pers. Med. 2014, 7, 65-77.
126. Koga, K., Matsumoto, K., Akiyoshi, T., Kubo, M. et al., Purification, characterization and biological significance of tumor-derived exosomes. Anticancer Res. 2005, 25, 3703-3707.
127. Choi, D. S., Lee, J. M., Park, G. W., Lim, H. W. et al., Proteomic analysis of microvesicles derived from human colorectal cancer cells. J. Proteome Res. 2007, 6, 4646-4655.
128. Ji, H., Greening, D. W., Barnes, T. W., Lim, J. W. et al., Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components. Proteomics 2013, 13, 1672-1686.
129. Wolfers, J., Lozier, A., Raposo, G., Regnault, A. et al., Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 2001, 7, 297-303.
130. Craven, R. A., Totty, N., Harnden, P., Selby, P. J. et al., Laser capture microdissection and two-dimensional polyacrylamide gel electrophoresis: evaluation of tissue preparation and sample limitations. Am. J. Pathol. 2002, 160, 815-822.
131. Marton, A., Vizler, C., Kusz, E., Temesfoi, V. et al., Melanoma cell-derived exosomes alter macrophage and dendritic cell functions in vitro. Immunol. Lett. 2012, 148, 34-38.
132. Hegmans, J. P., Bard, M. P., Hemmes, A., Luider, T. M. et al., Proteomic analysis of exosomes secreted by human mesothelioma cells. Am. J. Pathol. 2004, 164, 1807-1815.
133. Graner, M. W., Alzate, O., Dechkovskaia, A. M., Keene, J. D. et al., Proteomic and immunologic analyses of brain tumor exosomes. FASEB J. 2009, 23, 1541-1557.
134. Simpson, R. J., Jensen, S. S., Lim, J. W., Proteomic profiling of exosomes: current perspectives. Proteomics 2008, 8, 4083-4099.
135. Simpson, R. J., Lim, J. W., Moritz, R. L., Mathivanan, S., Exosomes: proteomic insights and diagnostic potential. Expert. Rev. Proteomics 2009, 6, 267-283.
136. Taylor, D. D., Zacharias, W., Gercel-Taylor, C., Exosome isolation for proteomic analyses and RN A profiling. Methods Mol. Biol. 2011, 728, 235-246.
137. Van Deun, J., Mestdagh, P., Sormunen, R., Cocquyt, V. et al. The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling. J. Extracell Vesicles 2014, 3, doi: 10.3402/jev.v3.24858
138. Taylor, D. D., Zacharias, W., Gercel-Taylor, C., Exosome isolation for proteomic analyses and RNA profiling. Methods Mol. Biol. 728, 235-246.
139. Marimpietri, D., Petretto, A., Raffaghello, L., Pezzolo, A. et al., Proteome profiling of neuroblastoma-derived exosomes reveal the expression of proteins potentially involved in tumor progression. PLoS One 2013, 8, e75054.
140. Raimondo, F., Corbetta, S., Morosi, L., Chinello, C. et al., Urinary exosomes and diabetic nephropathy: a proteomic approach. Mol. Biosyst. 2013, 9, 1139-1146.
141. Burke, M., Choksawangkarn, W., Edwards, N., Ostrand-Rosenberg, S. et al., Exosomes from myeloid-derived suppressor cells carry biologically active proteins. J. Proteome Res. 2014, 13, 836-843.
142. Street, J. M., Barran, P. E., Mackay, C. L., Weidt, S. et al. Identification and proteomic profiling of exosomes in human cerebrospinal fluid. J. Transl. Med. 2012, 10, 5.
143. Thery, C., Amigorena, S., Raposo, G., Clayton, A., Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. Chapter 2006, 3, Unit 3 22.
144. Marimuthu, A., Subbannayya, Y., Sahasrabuddhe, N. A., Balakrishnan, L. et al., SILAC-based quantitative proteomic analysis of gastric cancer secretome. Proteomics Clin. Appl. 2013, 7, 355-366.
145. Zhong, J., Krawczyk, S. A., Chaerkady, R., Huang, H. et al., Temporal profiling of the secretome during adipogenesis in humans. J. Proteome Res. 2010, 9, 5228-5238.
146. Cheung, W. C., Beausoleil, S. A., Zhang, X., Sato, S. et al., A proteomics approach for the identification and cloning of monoclonal antibodies from serum. Nat. Biotechnol. 2012, 30, 447-452.
147. Wine, Y., Boutz, D. R., Lavinder, J. J., Miklos, A. E. et al., Molecular deconvolution of the monoclonal antibodies that comprise the polyclonal serum response. Proc. Natl. Acad. Sci. USA 2013, 110, 2993-2998.
148. Perkins, D. N., Pappin, D. J., Creasy, D. M., Cottrell, J. S., Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20, 3551-3567.
149. Albaum, S. P., Hahne, H., Otto, A., Haussmann, U. et al. A guide through the computational analysis of isotope-labeled mass spectrometry-based quantitative proteomics data: an application study. Proteome Sci 2011, 9, 30.
150. Eng, J. K., McCormack, A. L., Yates, J. R., An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 1994, 5, 976-989.
151. Dasari, S., Chambers, M. C., Slebos, R. J., Zimmerman, L. J. et al. TagRecon: high-throughput mutation identification through sequence tagging. J. Proteome Res. 2010, 9, 1716-1726.
152. Zucht, H. D., Lamerz, J., Khamenia, V., Schiller, C. et al., Datamining methodology for LC-MALDI-MS based peptide profiling. Comb. Chem. High Throughput Screen 2005, 8, 717-723.
153. Palagi, P. M., Walther, D., Quadroni, M., Catherinet, S. et al., MSight: an image analysis software for liquid chromatography-mass spectrometry. Proteomics 2005, 5, 2381-2384.
154. Wang, W., Zhou, H., Lin, H., Roy, S. et al., Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards. Anal. Chem. 2003, 75, 4818-4826.
155. Kanehisa, M., Goto, S., Sato, Y., Kawashima, M. et al. Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res. 2014, 42, D199-D205.
156. Kanehisa, M., Goto, S., KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000, 28, 27-30.
157. Ashburner, M., Ball, C. A., Blake, J.A., Botstein, D. et al., Gene ontology: tool for the unification of biology. Gene Ontol. Consortium. Nat. Genet. 2000, 25, 25-29.
158. Cline, M. S., Smoot, M., Cerami, E., Kuchinsky, A. et al., Integration of biological networks and gene expression data using Cytoscape. Nat. Protoc. 2007, 2, 2366-2382.
159. Huang da W., Sherman, B. T., Lempicki, R. A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4, 44-57.
160. Huang da W., Sherman, B. T., Lempicki, R. A., Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009, 37, 1-13.
161. Krogh, A., Larsson, B., von Heijne, G., Sonnhammer, E. L., Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J. Mol. Biol. 2001, 305, 567-580.
162. Kall, L., Krogh, A., Sonnhammer, E. L., A combined transmembrane topology and signal peptide prediction method. J. Mol. Biol. 2004, 338, 1027-1036.
163. Emanuelsson, O., Nielsen, H., Brunak, S., von Heijne, G., Predicting subcellular localization of proteins based on their N-terminal amino acid sequence. J. Mol. Biol. 2000, 300, 1005-1016.
164. Bendtsen, J. D., Jensen, L. J., Blom, N., Von Heijne, G. et al., Feature-based prediction of non-classical and leaderless protein secretion. Protein Eng. Des. Sel. 2004, 17, 349-356.
165. Nakai, K., Kanehisa, M., A knowledge base for predicting protein localization sites in eukaryotic cells. Genomics 1992, 14, 897-911.
166. Horton, P., Park, K. J., Obayashi, T., Fujita, N. et al., WoLF PSORT: protein localization predictor. Nucleic Acids Res. 2007, 35, W585-W587.
167. Chen, Y., Zhang, Y., Yin, Y., Gao, G. et al., SPD-a web-based secreted protein database. Nucleic Acids Res. 2005, 33, D169-D173.
168. Cappadona, S., Baker, P. R., Cutillas, P. R., Heck, A. J. et al., Current challenges in software solutions for mass spectrometry-based quantitative proteomics. Amino Acids 2005, 43, 1087-1108.
169. R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. 2013. http://www.R-project.org/